Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 542 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
ORIGINAL ARTICLE Table of Contents   
Year : 2017  |  Volume : 28  |  Issue : 3  |  Page : 477-482
Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis


1 Department of Biochemistry, Institute of Medullasin, Kamakura; Fureai Clinic Izumi, Yokahama, Kanagawa, Japan
2 Department of Biochemistry, Institute of Medullasin, Kamakura, Japan

Correspondence Address:
Yosuke Aoki
Department of Biochemistry, Institute of Medullasin, Kamakura, Kanagawa
Japan
Login to access the Email id


DOI: 10.4103/1319-2442.206445

Rights and Permissions

Intravenous administration of 2 g carnitine in every hemodialysis (3 times/week), for 8–10 months, reduced doses of darbepoetin alfa required to maintain adequate hemoglobin levels (10–11 g/dL) into 10% of the initial doses. There was also a significant increase in plasma transferrin saturation, increase in left ventricular ejection fraction, and decrease in plasma brain natriuretic peptides.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed174    
    Printed10    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal